ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

New Guidelines Developed For Cancer Control Granters For Community Outreach

June 4, 1976

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995